180 related articles for article (PubMed ID: 33218846)
1. Impact of a national population-based carrier-screening program on spinal muscular atrophy births.
Aharoni S; Nevo Y; Orenstein N; Basel-Salmon L; Ben-Shachar S; Mussaffi H; Sagi-Dain L; Cohen R; Singer A
Neuromuscul Disord; 2020 Dec; 30(12):970-974. PubMed ID: 33218846
[TBL] [Abstract][Full Text] [Related]
2. Genetic carrier screening for spinal muscular atrophy and spinal muscular atrophy with respiratory distress 1 in an isolated population in Israel.
Basel-Vanagaite L; Taub E; Drasinover V; Magal N; Brudner A; Zlotogora J; Shohat M
Genet Test; 2008 Mar; 12(1):53-6. PubMed ID: 18298318
[TBL] [Abstract][Full Text] [Related]
3. Pan-ethnic carrier screening and prenatal diagnosis for spinal muscular atrophy: clinical laboratory analysis of >72,400 specimens.
Sugarman EA; Nagan N; Zhu H; Akmaev VR; Zhou Z; Rohlfs EM; Flynn K; Hendrickson BC; Scholl T; Sirko-Osadsa DA; Allitto BA
Eur J Hum Genet; 2012 Jan; 20(1):27-32. PubMed ID: 21811307
[TBL] [Abstract][Full Text] [Related]
4. Carrier screening for spinal muscular atrophy (SMA) in 107,611 pregnant women during the period 2005-2009: a prospective population-based cohort study.
Su YN; Hung CC; Lin SY; Chen FY; Chern JP; Tsai C; Chang TS; Yang CC; Li H; Ho HN; Lee CN
PLoS One; 2011 Feb; 6(2):e17067. PubMed ID: 21364876
[TBL] [Abstract][Full Text] [Related]
5. Carrier Screening and Prenatal Diagnosis for Spinal Muscular Atrophy in 13,069 Chinese Pregnant Women.
Zhang J; Wang Y; Ma D; Sun Y; Li Y; Yang P; Luo C; Jiang T; Hu P; Xu Z
J Mol Diagn; 2020 Jun; 22(6):817-822. PubMed ID: 32205292
[TBL] [Abstract][Full Text] [Related]
6. Reproductive genetic carrier screening for cystic fibrosis, fragile X syndrome, and spinal muscular atrophy in Australia: outcomes of 12,000 tests.
Archibald AD; Smith MJ; Burgess T; Scarff KL; Elliott J; Hunt CE; McDonald Z; Barns-Jenkins C; Holt C; Sandoval K; Siva Kumar V; Ward L; Allen EC; Collis SV; Cowie S; Francis D; Delatycki MB; Yiu EM; Massie RJ; Pertile MD; du Sart D; Bruno D; Amor DJ
Genet Med; 2018 Apr; 20(5):513-523. PubMed ID: 29261177
[TBL] [Abstract][Full Text] [Related]
7. A multi-source approach to determine SMA incidence and research ready population.
Verhaart IEC; Robertson A; Leary R; McMacken G; König K; Kirschner J; Jones CC; Cook SF; Lochmüller H
J Neurol; 2017 Jul; 264(7):1465-1473. PubMed ID: 28634652
[TBL] [Abstract][Full Text] [Related]
8. One Year of Newborn Screening for SMA - Results of a German Pilot Project.
Vill K; Kölbel H; Schwartz O; Blaschek A; Olgemöller B; Harms E; Burggraf S; Röschinger W; Durner J; Gläser D; Nennstiel U; Wirth B; Schara U; Jensen B; Becker M; Hohenfellner K; Müller-Felber W
J Neuromuscul Dis; 2019; 6(4):503-515. PubMed ID: 31594245
[TBL] [Abstract][Full Text] [Related]
9. Newborn and carrier screening for spinal muscular atrophy.
Prior TW; Snyder PJ; Rink BD; Pearl DK; Pyatt RE; Mihal DC; Conlan T; Schmalz B; Montgomery L; Ziegler K; Noonan C; Hashimoto S; Garner S
Am J Med Genet A; 2010 Jul; 152A(7):1608-16. PubMed ID: 20578137
[TBL] [Abstract][Full Text] [Related]
10. Population screening for spinal muscular atrophy: A mixed methods study of the views of affected families.
Boardman FK; Young PJ; Griffiths FE
Am J Med Genet A; 2017 Feb; 173(2):421-434. PubMed ID: 27792846
[TBL] [Abstract][Full Text] [Related]
11. [Carrier screening for spinal muscular atrophy in 4719 pregnant women in Shanghai region].
Gong B; Zhang L; Hou YP; Hu HY; Li HC; Tan MY; Chen J; Yu J
Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2013 Dec; 30(6):670-2. PubMed ID: 24327144
[TBL] [Abstract][Full Text] [Related]
12. Transmission ratio distortion in the spinal muscular atrophy locus: data from 314 prenatal tests.
Botta A; Tacconelli A; Bagni I; Giardina E; Bonifazi E; Pietropolli A; Clementi M; Novelli G
Neurology; 2005 Nov; 65(10):1631-5. PubMed ID: 16301493
[TBL] [Abstract][Full Text] [Related]
13. [Result of carrier screening for spinal muscular atrophy among 3049 reproductive-age individuals from Yunnan region].
Zhang Y; Wang L; He J; Guo J; Jin C; Tang X; Zhang J; Chen H; Zhang J; Su J; Zhu B
Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2020 Apr; 37(4):384-388. PubMed ID: 32219818
[TBL] [Abstract][Full Text] [Related]
14. Spinal muscular atrophy: newborn and carrier screening.
Prior TW
Obstet Gynecol Clin North Am; 2010 Mar; 37(1):23-36, Table of Contents. PubMed ID: 20494255
[TBL] [Abstract][Full Text] [Related]
15. Review of Spinal Muscular Atrophy (SMA) for Prenatal and Pediatric Genetic Counselors.
Carré A; Empey C
J Genet Couns; 2016 Feb; 25(1):32-43. PubMed ID: 26250347
[TBL] [Abstract][Full Text] [Related]
16. Diagnostic Testing for Patients with Spinal Muscular Atrophy.
Brandsema JF; Gross BN; Matesanz SE
Clin Lab Med; 2020 Sep; 40(3):357-367. PubMed ID: 32718505
[TBL] [Abstract][Full Text] [Related]
17. Epidemiological investigation of spinal muscular atrophy in Japan.
Ito M; Yamauchi A; Urano M; Kato T; Matsuo M; Nakashima K; Saito K
Brain Dev; 2022 Jan; 44(1):2-16. PubMed ID: 34452804
[TBL] [Abstract][Full Text] [Related]
18. Systemic nature of spinal muscular atrophy revealed by studying insurance claims.
Lipnick SL; Agniel DM; Aggarwal R; Makhortova NR; Finlayson SG; Brocato A; Palmer N; Darras BT; Kohane I; Rubin LL
PLoS One; 2019; 14(3):e0213680. PubMed ID: 30870495
[TBL] [Abstract][Full Text] [Related]
19. Incorporating Spinal Muscular Atrophy Analysis by Next-Generation Sequencing into a Comprehensive Multigene Panel for Neuromuscular Disorders.
Tan CA; Westbrook MJ; Truty R; Kvitek DJ; Kennemer M; Winder TL; Shieh PB
Genet Test Mol Biomarkers; 2020 Oct; 24(10):616-624. PubMed ID: 32721234
[No Abstract] [Full Text] [Related]
20. The prevalence of muscular dystrophy and spinal muscular atrophy in Croatia: data from national and non-governmental organization registries.
Draušnik Ž; Cerovečki I; Štefančić V; Mihel S; Stevanović R; Barišić N; Matković H; Melša M; Mirić M; Pjevač N; Benjak T
Croat Med J; 2019 Dec; 60(6):488-493. PubMed ID: 31894913
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
